Editorial
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Jul 28, 2021; 13(7): 223-226
Published online Jul 28, 2021. doi: 10.4329/wjr.v13.i7.223
Imaging in multiple myeloma: Computed tomography or magnetic resonance imaging?
Alberto Stefano Tagliafico
Alberto Stefano Tagliafico, Department of Health Sciences (DISSAL), University of Genova, Genova 16138, Italy
Author contributions: Tagliafico AS wrote this editorial.
Conflict-of-interest statement: Dr. Tagliafico has no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Alberto Stefano Tagliafico, MD, Associate Professor, Staff Physician, Department of Health Sciences (DISSAL), University of Genova, Via Balbi, 5, Genova 16138, Italy. alberto.tagliafico@unige.it
Received: March 15, 2021
Peer-review started: March 15, 2021
First decision: April 6, 2021
Revised: April 10, 2021
Accepted: June 18, 2021
Article in press: June 18, 2021
Published online: July 28, 2021
Processing time: 134 Days and 13.6 Hours
Core Tip

Core Tip: Introduction of new quantitative scores and biomarkers to predict multiple myeloma (MM) prognosis, possibly outperforming current staging methods to create new reliable standards for disease prediction and monitoring is an opportunity for further research in MM imaging.